Bifendatatum

CAS No. 73536-69-3

Bifendatatum( Bifendate )

Catalog No. M15813 CAS No. 73536-69-3

Bifendatatum is commonly used to treat the transaminase elevation that caused by viral hepatitis and drug induced liver injury.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
50MG 29 In Stock
100MG 41 In Stock
200MG 57 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Bifendatatum
  • Note
    Research use only, not for human use.
  • Brief Description
    Bifendatatum is commonly used to treat the transaminase elevation that caused by viral hepatitis and drug induced liver injury.
  • Description
    Bifendatatum is commonly used to treat the transaminase elevation that caused by viral hepatitis and drug induced liver injury.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Bifendate
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    73536-69-3
  • Formula Weight
    418.35
  • Molecular Formula
    C20H18O10
  • Purity
    >98% (HPLC)
  • Solubility
    Soluble in trichloromethane
  • SMILES
    O=C(C1=CC(OC)=C(OCO2)C2=C1C3=C4OCOC4=C(OC)C=C3C(OC)=O)OC
  • Chemical Name
    Methyl 7-methoxy-4-(7-methoxy-5-methoxycarbonyl-1,3-benzodioxol-4-yl)-1,3-benzodioxole-5-carboxylate

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Cyclo(L-Pro-L-Ile)

    Cyclo(L-Pro-L-Ile).

  • YK-2-69

    YK-2-69 is a highly selective DYRK2 inhibitor with anti-prostate cancer effects.

  • MIF-IN-2

    MIF-IN-2 is a heterocyclic macrophage migration inhibitory factor (MIF) inhibitor with anticancer activity for the study of cancer and autoimmune disorders.CAS ??13460-73-86-5